Handelsbanken Fonder AB Has $71.23 Million Stake in HCA Healthcare, Inc. $HCA

Key Points

• Handelsbanken Fonder AB reduced its HCA Healthcare stake by 4.1% in the second quarter, selling 7,712 shares and retaining 182,691 shares worth approximately $71.23 million. Institutional investors collectively own 62.73% of the company.
• HCA Healthcare reported quarterly earnings of $7.59 per share, slightly exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion. Analysts expect full-year earnings of $29.45 per share.
• Analyst sentiment remains a “Moderate Buy,” with 14 Buy, eight Hold, and one Sell rating and an average price target of $465.59. HCA also declared a quarterly dividend of $0.78 per share, equating to a 0.8% annual yield.

Handelsbanken Fonder AB lowered its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.1% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 182,691 shares of the company's stock after selling 7,712 shares during the period. Handelsbanken Fonder AB owned approximately 0.08% of HCA Healthcare worth $71,229,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Palisade Asset Management LLC acquired a new stake in HCA Healthcare during the third quarter worth approximately $26,000. Ares Financial Consulting LLC bought a new stake in HCA Healthcare during the fourth quarter worth $31,000. JPL Wealth Management LLC bought a new position in shares of HCA Healthcare in the 3rd quarter valued at $33,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $33,000. Finally, MCF Advisors LLC boosted its holdings in shares of HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company's stock valued at $34,000 after acquiring an additional 49 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent research reports. Mizuho decreased their price objective on HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a report on Tuesday, July 28th. Truist Financial lowered their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. Weiss Ratings downgraded HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, June 9th. JPMorgan Chase & Co. reduced their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a "neutral" rating for the company in a report on Tuesday, May 19th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a research note on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and an average target price of $465.59.

HCA Healthcare Stock Up 0.1%

HCA Healthcare stock opened at $413.78 on Tuesday. The company has a market capitalization of $89.58 billion, a P/E ratio of 13.85, a P/E/G ratio of 1.44 and a beta of 1.10. The firm has a 50 day moving average price of $389.86 and a 200-day moving average price of $448.25. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare's revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.84 earnings per share. Equities analysts expect that HCA Healthcare, Inc. will post 29.45 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is currently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source